QR Kodea

Benefit of adjuvant immunotherapy in renal cell carcinoma: A myth or a reality?

<h4>Background</h4>The benefit of adjuvant immunotherapy after nephrectomy in renal cell carcinoma (RCC) is controversial. The present study aimed to examine the possible benefit of adjuvant immunotherapy in various clinical settings.<h4>Methods</h4>We retrospectively reviewed 436 patients with pT1-...

Deskribapen osoa

Gorde:
Egile Nagusiak: Satoru Taguchi, Sebastiano Buti, Hiroshi Fukuhara, Masafumi Otsuka, Melissa Bersanelli, Teppei Morikawa, Hideyo Miyazaki, Tohru Nakagawa, Tetsuya Fujimura, Haruki Kume, Yasuhiko Igawa, Yukio Homma
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Public Library of Science (PLoS) 2017-01-01
Saila:PLoS ONE
Sarrera elektronikoa:https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0172341&type=printable
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak